TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05880537: Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

Sponsor: LifeNet Health · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$4,548,400

Rescue Site Savings

+$2,988,000

Unlock Full NCT05880537 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05880537 Rescue Dossier →